ATHN 11: Liver Transplantation Outcomes Study

Interested in this Trial?

Contact Us

Trial Status Completed

Trial Identifier

NCT04055051

Condition

Hemophilia A, Hemophilia A and B, Liver Transplantation

The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.

Trial Summary

This study is designed as a multi-center, observational cohort study of participants with hemophilia A and B who have and have not undergone liver transplantation. Participants will be asked to complete health related quality of life questionnaires and provide medical history.

Eligibility Criteria

Birth Sex

All

Age

From 18 Years

Healthy Volunteers

No

Study Type:

Observational

Number of Participants:

86

Study Started:

2020-06-18

Study Updated:

2023-05-10

Trial Locations

  • Orthopaedic Institute for Children Hemophilia Program

    Los Angeles, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • Bleeding and Clotting Disorders Institute

    Peoria, Illinois, United States

  • Indiana Hemophilia and Thrombosis Center (IHTC)

    Indianapolis, Indiana, United States

  • Maine Hemophilia and Thrombosis Center

    Scarborough, Maine, United States

  • Henry Ford Health System

    Detroit, Michigan, United States

  • Mayo Comprehensive Hemophilia Center

    Rochester, Minnesota, United States

  • Mary M. Gooley Hemophilia Center, Inc.

    Rochester, New York, United States

  • Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, United States

  • Ohio State University Medical Center Hemophilia Treatment Center

    Columbus, Ohio, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Gulf States Hemophilia and Thrombophilia Center

    Houston, Texas, United States

  • Utah Center for Bleeding and Clotting Disorders

    Salt Lake City, Utah, United States

  • Hemophilia Outreach Center Green Bay

    Green Bay, Wisconsin, United States

  • Comprehensive Center for Bleeding Disorders, Milwaukee

    Milwaukee, Wisconsin, United States

Inclusion Criteria

Inclusion Criteria

Participants who meet the following inclusion criteria are eligible for enrollment into the study:

1. Congenital hemophilia A or B of any severity, who have and have not undergone a liver transplant;
2. Age > 18; and
3. Sex assigned at birth was male

Exclusion Criteria

Exclusion Criteria

Participants who fall into any of the following exclusion criteria at the time of screening are not eligible for enrollment into the study:

1. Age <18

Contact BioMarin Clinical Trials

Please complete and submit the following form to express interest in participating and request more information about one of our clinical trials.

By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.

*required fields

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form